
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
At Sapience, we think boldly about the possibilities for treating cancer. We aim to discover and develop peptide therapeutics to address oncogenic and immunogenic dysregulation that drive cancer. Our pipeline of SPEARsTM (Stabilized Peptides Engineered Against Regulation) disrupt intracellular protein-protein interactions, enabling targeting of transcription factors which have traditionally been considered undruggable. We are advancing our lead programs, ST316, a first-in-class antagonist of -catenin, and ST101, a first-in-class antagonist of C/EBP, through Phase 1-2 clinical trials. Please engage with us on this platform to learn more!
Biotechnology and peptides
Sapience therapeutics, inc operates in the Biotechnology research industry.
Sapience therapeutics, inc's revenue is 11m - 100m
Sapience therapeutics, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.